BriaCell Therapeutics Corp (BCTXW) — Capital Reinvestment Ratio
Latest as of October 2012:
116.81x
BriaCell Therapeutics Corp (BCTXW) has a Capital Reinvestment Ratio of 116.81x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). See BCTXW free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
116.81x
Capex / Operating Cash Flow
Operating Cash Flow
$3.96K
USD
Capital Expenditures
$462.21K
USD
Data as of
Oct 2012
Most recent filing
Annual Capital Reinvestment Ratio for BriaCell Therapeutics Corp (None–None)
Year-by-year Capital Reinvestment Ratio for BriaCell Therapeutics Corp from None to None. For live market cap and broader valuation context, see BriaCell Therapeutics Corp (BCTXW) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow